Comments
Loading...

Teladoc Health Analyst Ratings

TDOCNYSE
Logo brought to you by Benzinga Data
$6.83
-0.07-1.01%
At close: -
$6.83
0.000.00%
After Hours: 7:40 PM EDT
Q1 2025 Earnings in 12 days from now on Wed Apr 30th, after the market close
Consensus Rating1
Hold
Highest Price Target1
$40.00
Lowest Price Target1
$8.00
Consensus Price Target1
$18.60

Teladoc Health Analyst Ratings and Price Targets | NYSE:TDOC | Benzinga

Teladoc Health Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Teladoc Health Corp from these most-recent analyst ratings.

Analyst Trends and Forecast
1
Dec 24
2
Jan
2
2
Feb
1
Mar
1
Apr
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
2.7
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

B of A Securities
Goldman Sachs
Piper Sandler
RBC Capital
Oppenheimer

1calculated from analyst ratings

Analyst Ratings for Teladoc Health

Buy NowGet Alert
04/11/2025Buy NowB of A Securities
Allen Lutz61%
$9.5 → $8MaintainsNeutralGet Alert
03/03/2025Buy NowGoldman Sachs
David Roman35%
$16 → $13MaintainsBuyGet Alert
02/27/2025Buy NowNeedham
Ryan MacDonald57%
ReiteratesHold → HoldGet Alert
02/27/2025Buy NowPiper Sandler
Jessica Tassan40%
$13 → $12MaintainsOverweightGet Alert
02/18/2025Buy NowGoldman Sachs
David Roman35%
$14 → $16MaintainsBuyGet Alert
02/12/2025Buy NowB of A Securities
Allen Lutz61%
$11.5 → $13.5MaintainsNeutralGet Alert
02/06/2025Buy NowB of A Securities
Allen Lutz61%
$10.5 → $11.5MaintainsNeutralGet Alert
01/24/2025Buy NowRBC Capital
Sean Dodge48%
$11 → $12MaintainsOutperformGet Alert
01/24/2025Buy NowOppenheimer
Michael Wiederhorn62%
$14 → $12MaintainsOutperformGet Alert
12/04/2024Buy NowPiper Sandler
Jessica Tassan40%
$11 → $13ReiteratesOverweight → OverweightGet Alert
11/15/2024Buy NowGoldman Sachs
David Roman35%
→ $14Initiates → BuyGet Alert
11/01/2024Buy NowDeutsche Bank
George Hill63%
$10 → $12MaintainsHoldGet Alert
10/31/2024Buy NowBarclays
Steve Valiquette54%
$10 → $12MaintainsOverweightGet Alert
10/31/2024Buy NowTD Cowen
Charles Rhyee37%
$9 → $8MaintainsHoldGet Alert
10/09/2024Buy NowRBC Capital
Sean Dodge48%
$9 → $10MaintainsOutperformGet Alert
10/08/2024Buy NowEvercore ISI Group
Elizabeth Anderson44%
$8 → $9MaintainsIn-LineGet Alert
09/17/2024Buy NowJefferies
Glen Santangelo50%
$8 → $10MaintainsHoldGet Alert
08/26/2024Buy NowJP Morgan
Lisa Gill60%
$16 → $9MaintainsNeutralGet Alert
08/20/2024Buy NowCantor Fitzgerald
Sarah James52%
$10 → $10ReiteratesOverweight → OverweightGet Alert
08/06/2024Buy NowPiper Sandler
Jessica Tassan40%
$25 → $10MaintainsOverweightGet Alert
08/02/2024Buy NowDeutsche Bank
George Hill63%
$15 → $10MaintainsHoldGet Alert
08/02/2024Buy NowTruist Securities
Jailendra Singh39%
$15 → $10MaintainsHoldGet Alert
08/01/2024Buy NowNeedham
Ryan MacDonald57%
Reiterates → HoldGet Alert
08/01/2024Buy NowTD Cowen
Charles Rhyee37%
$15 → $9MaintainsHoldGet Alert
08/01/2024Buy NowRBC Capital
Sean Dodge48%
$18 → $9MaintainsOutperformGet Alert
08/01/2024Buy NowBarclays
Steve Valiquette54%
$20 → $10MaintainsOverweightGet Alert
08/01/2024Buy NowStifel
David Grossman63%
$16 → $9MaintainsHoldGet Alert
08/01/2024Buy NowDA Davidson
Gil Luria50%
$12 → $8MaintainsNeutralGet Alert
08/01/2024Buy NowCanaccord Genuity
Richard Close46%
$25 → $17MaintainsBuyGet Alert
08/01/2024Buy NowOppenheimer
Michael Wiederhorn62%
$21 → $17MaintainsOutperformGet Alert
07/09/2024Buy NowEvercore ISI Group
Elizabeth Anderson44%
$14 → $10MaintainsIn-LineGet Alert
05/21/2024Buy NowJP Morgan
Lisa Gill60%
$19 → $16MaintainsNeutralGet Alert
05/20/2024Buy NowJefferies
Glen Santangelo50%
$16 → $14MaintainsHoldGet Alert
05/14/2024Buy NowB of A Securities
Allen Lutz61%
$16.5 → $13.5MaintainsNeutralGet Alert
04/29/2024Buy NowWells Fargo
Stephen Baxter58%
$17 → $15MaintainsEqual-WeightGet Alert
04/26/2024Buy NowOppenheimer
Michael Wiederhorn62%
$26 → $21MaintainsOutperformGet Alert
04/26/2024Buy NowTD Cowen
Charles Rhyee37%
$16 → $15MaintainsHoldGet Alert
04/26/2024Buy NowEvercore ISI Group$15 → $14MaintainsIn-LineGet Alert
04/26/2024Buy NowRBC Capital
Sean Dodge48%
$25 → $18MaintainsOutperformGet Alert
04/26/2024Buy NowStifel
David Grossman63%
$21 → $16MaintainsHoldGet Alert
04/26/2024Buy NowBarclays
Steve Valiquette54%
$25 → $20MaintainsOverweightGet Alert
04/26/2024Buy NowCanaccord Genuity
Richard Close46%
$28 → $25MaintainsBuyGet Alert
04/26/2024Buy NowNeedham
Ryan MacDonald57%
Reiterates → HoldGet Alert
04/05/2024Buy NowNeedham
Ryan MacDonald57%
Reiterates → HoldGet Alert
03/06/2024Buy NowTruist Securities
Jailendra Singh39%
$23 → $17MaintainsHoldGet Alert
02/29/2024Buy NowCantor Fitzgerald
Sarah James52%
→ $22Initiates → OverweightGet Alert
02/26/2024Buy NowLeerink Partners
Michael Cherny79%
→ $17Initiates → Market PerformGet Alert
02/21/2024Buy NowDA Davidson
Gil Luria50%
$22 → $18MaintainsNeutralGet Alert
02/21/2024Buy NowCitigroup
Daniel Grosslight44%
$21 → $19MaintainsNeutralGet Alert
02/21/2024Buy NowRBC Capital
Sean Dodge48%
$30 → $25MaintainsOutperformGet Alert
02/21/2024Buy NowBarclays
Steve Valiquette54%
$26 → $25MaintainsOverweightGet Alert
02/21/2024Buy NowPiper Sandler
Jessica Tassan40%
$30 → $25MaintainsOverweightGet Alert
02/21/2024Buy NowCanaccord Genuity
Richard Close46%
$34 → $28MaintainsBuyGet Alert
11/17/2023Buy NowJP Morgan
Lisa Gill60%
$33 → $19MaintainsNeutralGet Alert
10/25/2023Buy NowRBC Capital
Sean Dodge48%
$35 → $30MaintainsOutperformGet Alert
10/25/2023Buy NowOppenheimer
Michael Wiederhorn62%
$35 → $26MaintainsOutperformGet Alert
10/23/2023Buy NowCitigroup
Daniel Grosslight44%
$29 → $21MaintainsNeutralGet Alert
10/20/2023Buy NowCitigroup
Daniel Grosslight44%
$29 → $21MaintainsNeutralGet Alert
09/25/2023Buy NowTruist Securities
Jailendra Singh39%
→ $28ReiteratesHold → HoldGet Alert
07/26/2023Buy NowStephens & Co.
Jeff Garro40%
→ $28ReiteratesEqual-Weight → Equal-WeightGet Alert
07/26/2023Buy NowRBC Capital
Sean Dodge48%
→ $35ReiteratesOutperform → OutperformGet Alert
07/26/2023Buy NowCitigroup
Daniel Grosslight44%
$31 → $29MaintainsNeutralGet Alert
07/26/2023Buy NowCredit Suisse
Jonathan Yong65%
→ $27ReiteratesNeutral → NeutralGet Alert
04/28/2023Buy NowDeutsche Bank
George Hill63%
$27 → $29MaintainsHoldGet Alert
04/27/2023Buy NowCitigroup
Daniel Grosslight44%
$30 → $31MaintainsNeutralGet Alert
04/27/2023Buy NowRBC Capital
Sean Dodge48%
→ $35Reiterates → OutperformGet Alert
04/27/2023Buy NowCredit Suisse
Jonathan Yong65%
→ $27Reiterates → NeutralGet Alert
04/27/2023Buy NowBarclays
Steve Valiquette54%
$28 → $29MaintainsEqual-WeightGet Alert
04/12/2023Buy NowStephens & Co.
Jeff Garro40%
→ $25Initiates → Equal-WeightGet Alert
03/10/2023Buy NowCredit Suisse
Jonathan Yong65%
$30 → $27MaintainsNeutralGet Alert
03/06/2023Buy NowCanaccord Genuity
Richard Close46%
$40 → $36MaintainsBuyGet Alert
03/06/2023Buy NowWells Fargo
Stan Berenshteyn40%
$28 → $23MaintainsEqual-WeightGet Alert
02/28/2023Buy NowCitigroup
Daniel Grosslight44%
$33 → $30MaintainsNeutralGet Alert
02/27/2023Buy NowDeutsche Bank
George Hill63%
$31 → $27MaintainsHoldGet Alert
02/27/2023Buy NowJP Morgan
Lisa Gill60%
$35 → $33MaintainsNeutralGet Alert
02/23/2023Buy NowOppenheimer
Michael Wiederhorn62%
$37 → $35MaintainsOutperformGet Alert
02/23/2023Buy NowRBC Capital
Sean Dodge48%
→ $35Reiterates → OutperformGet Alert
02/23/2023Buy NowSVB Leerink
Stephanie Davis40%
→ $34UpgradeMarket Perform → OutperformGet Alert
01/19/2023Buy NowOppenheimer
Colin Rusch53%
$45 → $37MaintainsOutperformGet Alert
01/18/2023Buy NowBarclays
Marc Solecitto60%
$32 → $28MaintainsEqual-WeightGet Alert
12/13/2022Buy NowCitigroup
Daniel Grosslight44%
$36 → $33MaintainsNeutralGet Alert
10/31/2022Buy NowCredit Suisse
Jonathan Yong65%
$35 → $30MaintainsNeutralGet Alert
10/27/2022Buy NowCitigroup
Daniel Grosslight44%
$38 → $36MaintainsNeutralGet Alert
10/27/2022Buy NowBarclays
Steve Valiquette54%
$33 → $32MaintainsEqual-WeightGet Alert
10/25/2022Buy NowDA Davidson
Robert Simmons52%
$45 → $40MaintainsBuyGet Alert
10/24/2022Buy NowGuggenheim
Sandy Draper73%
UpgradeSell → NeutralGet Alert
10/21/2022Buy NowTruist Securities
Jailendra Singh39%
$35 → $29MaintainsHoldGet Alert
10/11/2022Buy NowBarclays
Steve Valiquette54%
$40 → $33MaintainsEqual-WeightGet Alert
09/28/2022Buy NowRBC Capital
Sean Dodge48%
$53 → $35MaintainsOutperformGet Alert
09/27/2022Buy NowDeutsche Bank
George Hill63%
$34 → $31MaintainsHoldGet Alert
09/16/2022Buy NowKeybanc
Scott Schoenhaus45%
Initiates → Sector WeightGet Alert
09/07/2022Buy NowTruist Securities
Jailendra Singh39%
→ $35Initiates → HoldGet Alert
08/17/2022Buy NowGuggenheim
Sandy Draper73%
→ $25DowngradeNeutral → SellGet Alert
08/12/2022Buy NowDA Davidson
Robert Simmons52%
→ $45Initiates → BuyGet Alert
08/02/2022Buy NowBerenberg
Ravi Misra34%
$42 → $35DowngradeBuy → HoldGet Alert
08/02/2022Buy NowCowen & Co.
Charles Rhyee37%
$58 → $34DowngradeOutperform → Market PerformGet Alert
07/28/2022Buy NowGoldman Sachs
Cindy Motz29%
$55 → $36DowngradeBuy → NeutralGet Alert
07/28/2022Buy NowBarclays
Steve Valiquette54%
$42 → $40MaintainsEqual-WeightGet Alert
07/28/2022Buy NowNeedham
Ryan MacDonald57%
DowngradeBuy → HoldGet Alert
07/28/2022Buy NowPiper Sandler
Jessica Tassan40%
$42 → $40MaintainsOverweightGet Alert

FAQ

Q

What is the target price for Teladoc Health (TDOC) stock?

A

The latest price target for Teladoc Health (NYSE:TDOC) was reported by B of A Securities on April 11, 2025. The analyst firm set a price target for $8.00 expecting TDOC to rise to within 12 months (a possible 17.13% upside). 43 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Teladoc Health (TDOC)?

A

The latest analyst rating for Teladoc Health (NYSE:TDOC) was provided by B of A Securities, and Teladoc Health maintained their neutral rating.

Q

When was the last upgrade for Teladoc Health (TDOC)?

A

The last upgrade for Teladoc Health Inc happened on February 23, 2023 when SVB Leerink raised their price target to $34. SVB Leerink previously had a market perform for Teladoc Health Inc.

Q

When was the last downgrade for Teladoc Health (TDOC)?

A

The last downgrade for Teladoc Health Inc happened on August 17, 2022 when Guggenheim changed their price target from N/A to $25 for Teladoc Health Inc.

Q

When is the next analyst rating going to be posted or updated for Teladoc Health (TDOC)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Teladoc Health, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Teladoc Health was filed on April 11, 2025 so you should expect the next rating to be made available sometime around April 11, 2026.

Q

Is the Analyst Rating Teladoc Health (TDOC) correct?

A

While ratings are subjective and will change, the latest Teladoc Health (TDOC) rating was a maintained with a price target of $9.50 to $8.00. The current price Teladoc Health (TDOC) is trading at is $6.83, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch